Dynastat

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2011
01220042011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Particle-wear-induced inflammatory osteolysis remains a major problem for the long-term success of total joint arthroplasty… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
BACKGROUND Aspirin-exacerbated respiratory disease (AERD) affects a subset of patients with asthma. Cyclooxygenase 2 inhibitors… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Making meaningful comparisons between the performance of the various speech enhancement algorithms proposed over the years, has… (More)
  • table 2
  • figure 1
  • table 3
  • figure 3
  • figure 4
Is this relevant?
2006
2006
A follow-up of 180 women was carried out. The patients having endured different gynecological operations (laparoscopy… (More)
Is this relevant?
2005
2005
Selective inhibitors of cyclooxygenase (COX)-2 1 depress prostacyclin (PGI2) but not COX-1–derived thromboxane A2. The effects of… (More)
Is this relevant?
2005
2005
A follow-up of forty women was carried out. The patients having endured a gynecological operation (laparohysterectomy) were… (More)
Is this relevant?
2004
2004
  • 2004
 
  • table 1
  • table 2
  • table 4
  • table 5
  • table 6
Is this relevant?
Review
2004
Review
2004
Parecoxib (Dynastat) is a parenteral cyclooxygenase-2 inhibitor available in Europe. Clinical trials have reported a benefit in… (More)
Is this relevant?